Proteon Pharmaceuticals S.A. uses precision biology for microbiome modulation to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics. PROTEON's products improve the economic efficiency in livestock farming and aquaculture, increasing environmental sustainability with natural products that also enhance animal welfare.
$25M sweet spot round size
2005
$25M
from 3 investors over 1 rounds
Proteon Pharmaceuticals raised $25M on September 10, 2021
Investors: Aqua Spark, Nutreco and + 3 Other investors